Access cutting-edge sickle cell crisis treatment through this clinical trial at a research site in Milwaukee. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Milwaukee location
Preparing your pre-screening questions…
Access sickle cell crisis specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related sickle cell crisis treatment provided free
Check if you qualify for this sickle cell crisis clinical trial in Milwaukee, WI
No-Cost Study Care
Local to Milwaukee
Convenient for WI residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Sickle cell disease (SCD) is an inherited blood disorder affecting approximately 36,000 children in the United States, approximately 90% of whom are Black. The disease is characterized by recurrent, severe pain crises which result in high rates of emergency department visits and hospitalizations, and decreased quality of life. The National Heart, Lung and Blood Institute, as well as the American Society of Hematology, have endorsed pain management guidelines regarding the timeliness of care for children presenting with these acute pain crises. These evidence-based guidelines are infrequently followed, resulting in increased pain and hospitalizations. In additional to other barriers to following the guideline, structural racism has been proposed as a significant contributor and the New England Journal of Medicine recently called for the institution of SCD-specific pain management protocols to combat structural racism and reduce time to opioid administration. The investigators' long-term goal is to improve the care and health outcomes of children with acute painful vaso-occlusive crisis treated in the emergency department. The overall aim of the investigators is to test a care pathway using multifaceted implementation strategies to increase guideline adherent care for children in the emergency department with acute painful vaso-occlusive crisis.
Sponsor: Medical College of Wisconsin
Yes, this clinical trial (NCT05373771) has an active research site in Milwaukee, WI that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for sickle cell crisis treatment options in Milwaukee, WI, this clinical trial (NCT05373771) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Milwaukee research site is actively enrolling participants for this clinical trial. You'll receive care from experienced sickle cell crisis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all sickle cell crisis clinical trials near you to find additional studies recruiting in your area.
See all interstitial cystitis clinical trials recruiting in Milwaukee — not just this study.
Browse Interstitial Cystitis Trials in Milwaukee →